Literature DB >> 3354923

Acute cardiogenic pulmonary edema: clinical and noninvasive evaluation.

A J Bier1, P Q Eichacker, L I Sinoway, S M Terribile, J A Strom, D L Keefe.   

Abstract

Left ventricular echocardiograms performed within ninety-six hours of admission were prospectively correlated with the clinical course in 87 consecutive patients admitted with acute pulmonary edema. Patients were stratified into four groups based on their two-dimensional echocardiogram: hyperdynamic, normal, mildly reduced, and severely reduced. Echocardiographic estimates of left ventricular function were compared with their ejection fraction measured by the gated radioisotope technique. The authors found that 48% of the patients were either normal or hyperdynamic (38% and 10% respectively). Patients in these two groups had a greater incidence of left ventricular hypertrophy (wall thickness greater than 13 mm) (66% vs 39%, p less than .05), hypertension on admission (BP greater than 160/100) (66% vs 41%, p = .05), and smaller end-diastolic dimension (p less than .05) than those with decreased left ventricular function. The authors conclude that echocardiography is a good screening test of left ventricular function in patients presenting with pulmonary edema. Patients with normal or increased left ventricular systolic function should be evaluated for correctable or treatable causes of acute pulmonary edema.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  1988        PMID: 3354923     DOI: 10.1177/000331978803900302

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

Review 1.  How well can the chest radiograph diagnose left ventricular dysfunction?

Authors:  R G Badgett; C D Mulrow; P M Otto; G Ramírez
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

2.  Risk factors for intubation as a guide for noninvasive ventilation in patients with severe acute cardiogenic pulmonary edema.

Authors:  Josep Masip; Joaquim Páez; Montserrat Merino; Sandra Parejo; Francisco Vecilla; Clara Riera; Araceli Ríos; Joan Sabater; Josep Ballús; J Padró
Journal:  Intensive Care Med       Date:  2003-09-10       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.